What's breaking now, across thousands of outlets.
It's a decision that could end up hurting the person you love most.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Key PointsAmgen is a diversified pharmaceutical giant with high net margins. It reported nearly $8.1 billion in free cash flow for fiscal 2025.
Key PointsThe nuclear energy sector is seeing renewed interest, driving a wave of investments and initial public offerings.
Key PointsThe U.S. has a large burden of debt, and it's getting harder to service.
